Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tammy Bigwarfe

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Bioanalysis|November 22, 2018
Application of Mitra<sup>®</sup> microsampling for pharmacokinetic bioanalysis of monoclonal antibodies in ratsHua Li, Tammy Bigwarfe, Maria Myzithras, et al.
Bioanalysis|June 8, 2026
Preclinical pharmacokinetics of novel MYDGF for human PK and dose predictionMaria Myzithras, Wei Wei, Tammy Bigwarfe, et al.
Mabs|September 7, 2016
Utility of immunodeficient mouse models for characterizing the preclinical pharmacokinetics of immunogenic antibody therapeuticsMaria Myzithras, Tammy Bigwarfe, Hua Li, et al.
Bioanalysis|February 17, 2018
Optimizing NBE PK/PD assays using the Gyrolab Affinity Software; conveniently within the bioanalyst's existing workflowMaria Myzithras, Tammy Bigwarfe, Erica Waltz, et al.
Bioanalysis|February 27, 2016
Development of an ultra-sensitive Simoa assay to enable GDF11 detection: a comparison across bioanalytical platformsMaria Myzithras, Hua Li, Tammy Bigwarfe, et al.
Mabs|September 11, 2018
Non-neutralizing antibodies increase endogenous circulating Ang1 levelsChao Zheng, Joshuaine Toth, Tammy Bigwarfe, et al.
Mabs|August 9, 2017
Maximizing in vivo target clearance by design of pH-dependent target binding antibodies with altered affinity to FcRnDanlin Yang, Craig Giragossian, Steven Castellano, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 2, 2022
Effect of Novel Biotherapeutic Elevating Angiopoietin 1 on Progression of Diabetic Nephropathy in Diabetic/Obese MicePeng Sun, Christina S Bartlett, Chao Zheng, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Bioanalysis|November 22, 2018
Application of Mitra<sup>®</sup> microsampling for pharmacokinetic bioanalysis of monoclonal antibodies in ratsHua Li, Tammy Bigwarfe, Maria Myzithras, et al.
Bioanalysis|June 8, 2026
Preclinical pharmacokinetics of novel MYDGF for human PK and dose predictionMaria Myzithras, Wei Wei, Tammy Bigwarfe, et al.
Mabs|September 7, 2016
Utility of immunodeficient mouse models for characterizing the preclinical pharmacokinetics of immunogenic antibody therapeuticsMaria Myzithras, Tammy Bigwarfe, Hua Li, et al.
Bioanalysis|February 17, 2018
Optimizing NBE PK/PD assays using the Gyrolab Affinity Software; conveniently within the bioanalyst's existing workflowMaria Myzithras, Tammy Bigwarfe, Erica Waltz, et al.
Bioanalysis|February 27, 2016
Development of an ultra-sensitive Simoa assay to enable GDF11 detection: a comparison across bioanalytical platformsMaria Myzithras, Hua Li, Tammy Bigwarfe, et al.
Mabs|September 11, 2018
Non-neutralizing antibodies increase endogenous circulating Ang1 levelsChao Zheng, Joshuaine Toth, Tammy Bigwarfe, et al.
Mabs|August 9, 2017
Maximizing in vivo target clearance by design of pH-dependent target binding antibodies with altered affinity to FcRnDanlin Yang, Craig Giragossian, Steven Castellano, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 2, 2022
Effect of Novel Biotherapeutic Elevating Angiopoietin 1 on Progression of Diabetic Nephropathy in Diabetic/Obese MicePeng Sun, Christina S Bartlett, Chao Zheng, et al.
Pageof 1